Medical Genetics

Medical Genetics refers to cannabis breeding programs developed with selection for specific cannabinoid ratios, terpene profiles, and consistent plant architecture — traits often valued in research and clinical contexts. These lineages typically emphasize reproducibility, documented parentage, and chemotype stability rather than novelty or potency alone. Breeders working in this category frequently prioritize CBD-dominant, balanced CBD:THC, or minor-cannabinoid-rich cultivars, though the term is descriptive of breeding methodology rather than a legal or regulatory category. Medical Genetics strains often trace to foundational lines selected for predictable phenotypes across generations. This focus on reliability and genetic transparency has influenced both commercial seed banking and institutional cannabis research programs.

Breeders use Medical Genetics frameworks to establish stable F1 hybrids and inbred lines suitable for controlled cultivation and consistent cannabinoid/terpene output. Lineage records and breeding documentation are central to this classification, enabling reproducibility across multiple crop cycles.